Kamran Alam

Insider Reports History

Entity
Individual
Location
350 Fifth Avenue, Suite 7530, New York, NY
Signature
/s/ Kamran Alam
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kamran Alam:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Taysha Gene Therapies, Inc. CHIEF FINANCIAL OFFICER Common Stock 1.24M $2.1M $1.69 Mar 11, 2025 Direct
Taysha Gene Therapies, Inc. CHIEF FINANCIAL OFFICER Employee Stock Option (right to buy) 431K Jan 2, 2025 Direct

Insider Reports Filed by Kamran Alam

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TSHA Taysha Gene Therapies, Inc. Mar 11, 2025 1 -$50.4K 4 Mar 13, 2025 CHIEF FINANCIAL OFFICER
TSHA Taysha Gene Therapies, Inc. Jan 2, 2025 2 $0 4 Jan 3, 2025 CHIEF FINANCIAL OFFICER
TSHA Taysha Gene Therapies, Inc. Feb 2, 2024 1 -$1.94K 4 Feb 6, 2024 CHIEF FINANCIAL OFFICER
TSHA Taysha Gene Therapies, Inc. Jan 2, 2024 2 $0 4 Jan 4, 2024 Chief Financial Officer
TSHA Taysha Gene Therapies, Inc. Dec 14, 2023 1 $0 4 Dec 18, 2023 Chief Financial Officer
TSHA Taysha Gene Therapies, Inc. Aug 24, 2023 1 -$76.9K 4 Aug 25, 2023 Chief Financial Officer
TSHA Taysha Gene Therapies, Inc. May 31, 2023 1 $0 4/A Apr 10, 2025 CHIEF FINANCIAL OFFICER
TSHA Taysha Gene Therapies, Inc. Feb 2, 2023 3 $0 4 Feb 6, 2023 Chief Financial Officer
TSHA Taysha Gene Therapies, Inc. Aug 23, 2022 1 -$11.5K 4 Aug 24, 2022 Chief Financial Officer
TSHA Taysha Gene Therapies, Inc. Aug 18, 2022 3 -$106K 4 Aug 22, 2022 Chief Financial Officer
TSHA Taysha Gene Therapies, Inc. Apr 6, 2022 1 $0 4 Apr 8, 2022 Chief Financial Officer
TSHA Taysha Gene Therapies, Inc. Feb 23, 2022 1 $0 4 Feb 25, 2022 Chief Financial Officer
TSHA Taysha Gene Therapies, Inc. Aug 18, 2021 5 -$557K 4 Aug 20, 2021 Chief Financial Officer